Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

By F. J. Ibarrondo, J. Fulcher, David Goodman-Meza, J. Elliott, C. Hofmann, M. Hausner, Kathie G Ferbas, Nicole H. Tobin, G. Aldrovandi, O. Yang. New England Journal of Medicine, 2020

1,001 citations recorded by the source corpus.

Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...

Subfields: Infectious Diseases, Neurology

View Paper: https://www.semanticscholar.org/paper/cd000aa1c45f4082d666322000ab782b0ae71cc8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Björkström
2. T. Sekine
3. H. Ljunggren
4. Tiphaine Parrot
5. Habiba Kamal
6. J. Gorin
7. S. Llewellyn-Lacey
8. Morten Nielsen

Citations in the corpus

• Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy (2020, neutral): “As the long-term immunity induced by natural infection or vaccination may decay in as little as 2–4 months (Ibarrondo et al., 2020; Long et al., 2020), the need for rapid and frequent testing for SARS-CoV-2 will likely remain.”
• Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients (2020, neutral): “However, these findings differ with other recent studies suggesting a more rapid waning in anti-RBD titers following mild or asymptomatic SARS-CoV-2 infection (11, 12).”
• Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 (2020, positive): “Antibody responses have also been shown to wane after infection with SARS-CoV-2 (Ibarrondo et al., 2020; Long et al., 2020), suggesting that transient humoral immunity is a general feature of coronavirus infections (Callow et al.”